"Tumor Protein p73" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A homolog of p53 TUMOR SUPPRESSOR PROTEIN that encodes full-length trans-activating and N-terminally-truncated (DeltaN) isoforms. Detection of splice variants and isoforms in the nervous system (human TELENCEPHALON, CHOROID PLEXUS; CEREBROSPINAL FLUID), embryonic tissue, human BREAST CANCER; OVARIAN CANCER, suggest roles in cellular differentiation.
| Descriptor ID |
D000072160
|
| MeSH Number(s) |
D12.776.260.885 D12.776.624.776.820 D12.776.660.912 D12.776.930.969
|
| Concept/Terms |
Tumor Protein p73- Tumor Protein p73
- Protein p73, Tumor
- p73, Tumor Protein
- Protein p73
- p73, Protein
- p73 Protein
- Protein, p73
- Tumor Suppressor Protein p73
- Tap73 Protein, Human
- Human Tap73 Protein
- Protein, Human Tap73
|
Below are MeSH descriptors whose meaning is more general than "Tumor Protein p73".
Below are MeSH descriptors whose meaning is more specific than "Tumor Protein p73".
This graph shows the total number of publications written about "Tumor Protein p73" by people in this website by year, and whether "Tumor Protein p73" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 4 | 4 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 0 | 2 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Protein p73" by people in Profiles.
-
p73 regulates epidermal wound healing and induced keratinocyte programming. PLoS One. 2019; 14(6):e0218458.
-
Do some epithelial ovarian cancers originate from a fallopian tube ciliate cell lineage? Med Hypotheses. 2017 Sep; 107:16-21.
-
The p53 family members have distinct roles during mammalian embryonic development. Cell Death Differ. 2017 04; 24(4):575-579.
-
De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia. J Med Genet. 2017 02; 54(2):84-86.
-
De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia. J Med Genet. 2017 02; 54(2):84-86.
-
IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature. 2015 Jan 29; 517(7536):626-30.
-
Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck. Carcinogenesis. 2013 Jul; 34(7):1551-7.
-
Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer. PLoS One. 2012; 7(4):e35522.
-
Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. Cancer Cell. 2012 Feb 14; 21(2):196-211.
-
Combined p53-related genetic variants together with HPV infection increase oral cancer risk. Int J Cancer. 2012 Aug 01; 131(3):E251-8.